Abstract
One hundred four patients with advanced colon carcinoma were treated with mitoxantrone 5 mg/m2 I.V. weekly. The patients were stratified into two groups: prior chemotherapy and no prior chemotherapy. Only one partial response was noted in the prior treatment category.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Anthraquinones / adverse effects
-
Anthraquinones / therapeutic use*
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Colonic Neoplasms / drug therapy*
-
Drug Evaluation
-
Humans
-
Mitoxantrone
-
Neoplasm Metastasis
-
Rectal Neoplasms / drug therapy*
Substances
-
Anthraquinones
-
Antineoplastic Agents
-
Mitoxantrone